Biocon, a leading biotechnology firm, announced a dramatic increase in its consolidated profit after tax for the first quarter ending June 2024. The company’s profit surged more than six times to ₹660 crore, driven by a significant one-time gain resulting from its collaboration with Eris Lifesciences through Biocon Biologics.
The substantial profit growth highlights the impact of strategic…
